Novo Nordisk Income Statement
View: Annual | Quarterly
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Revenue | 8,261.6 | 6,857.5 | 5,351.0 |
| Cost of Goods Sold | 1,934.1 | 1,696.5 | 1,454.6 |
| Gross Profit | 6,327.5 | 5,161.0 | 3,896.4 |
| Gross Profit Margin | 76.6% | 75.3% | 72.8% |
| SG&A Expense | 3,967.6 | 3,218.4 | 2,354.7 |
| Depreciation & Amortization | 593.9 | 379.1 | 305.9 |
| Operating Income | 1,766.0 | 1,563.4 | 1,235.8 |
| Operating Margin | 21.4% | 22.8% | 23.1% |
| Nonoperating Income | 464.7 | 131.9 | (43.6) |
| Nonoperating Expenses | 64.0 | 52.4 | 40.3 |
| Income Before Taxes | 2,166.8 | 1,642.9 | 1,198.1 |
| Income Taxes | 483.7 | 480.0 | 375.6 |
| Net Income After Taxes | 1,683.1 | 1,162.9 | 822.5 |
| Continuing Operations | 1,683.1 | 1,116.9 | 776.3 |
| Discontinued Operations | -- | -- | -- |
| Total Operations | 1,683.1 | 1,116.9 | 776.3 |
| Total Net Income | 1,683.1 | 1,116.9 | 776.3 |
| Net Profit Margin | 20.4% | 16.3% | 14.5% |
| Diluted EPS from Total Net Income ($) | -- | 1.73 | 1.17 |
| Dividends per Share | 0.62 | 0.35 | 0.31 |





